Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

K2M boosts biologics offering by expanding osteobiologic product family

K2M : 25 April, 2013  (New Product)
K2M is revealing another expansion of the company's US biologics offering with the addition of a new product line to the VESUVIUS Osteobiologic Systems.


VESUVIUS DBM Putty will join the rapidly growing portfolio already featuring VESUVIUS Demineralized Fibers and VESUVIUS Demineralized Sponge. Processed by LifeNet Health, a leading allograft bio-implant and regenerative medicine company, the products are treated with a patented ALLOWASH XG sterilization process and PAD demineralization technology to protect Bone Morphogenic Proteins (BMPs), while ensuring optimal osteoinductive potential. VESUVIUS DBM Putty incorporates proprietary bone-fibre technology and a glycerol carrier to provide an enlarged surface area to facilitate attachment, migration, and distribution of cells within the graft material.



Paul Savas, MD, K2M’s Medical Director for Tissue Products and orthopaedic surgeon in Williamsburg, Virginia, said: "K2M's launch of VESUVIUS DBM Putty is an important expansion of their biologics portfolio. DBM Putty is a commonly used osteobiologics solution for spinal fusions, and this offering incorporates a unique carrier for handling characteristics, while incorporating LifeNet’s PAD process to achieve the ideal residual calcium necessary for optimal osteoinductive potential. Products can be designated as demineralized if the residual calcium level is less than eight percent. However, studies show that residual calcium in the range of one to four percent provides the most osteoinductive potential. This is the range that the PAD process targets consistently."



"The launch of this new addition to the VESUVIUS product family demonstrates K2M's continued focus on growing our presence in the biologics market," said Eric Major, K2M's President and Chief Executive Officer. "VESUVIUS DBM Putty complements and enhances K2M's comprehensive and innovative spine portfolio."


Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo